Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
0.67
Jun. 09, 2026 16:00:01- Change 0.0121 (1.83723%)
- Volume 76,597
- Today's Open 0.6375
- Previous Close 0.6586
- Today's High 0.6708
- Today's Low 0.6311
- 52 Week High 1.96
- 52 Week Low 0.281